• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparative Evaluation of Surgical Operability with and without Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.局部晚期头颈部鳞状细胞癌诱导化疗前后手术可切除性的比较评估
Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):626-632. doi: 10.1007/s12070-023-04230-1. Epub 2023 Oct 3.
2
Response Rate of Cisplatin Plus Docetaxel as Primary Treatment in Locally Advanced Head and Neck Carcinoma (Squamous Cell Types).顺铂联合多西他赛作为局部晚期头颈癌(鳞状细胞类型)一线治疗的缓解率
Asian Pac J Cancer Prev. 2020 Mar 1;21(3):825-830. doi: 10.31557/APJCP.2020.21.3.825.
3
Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.表皮生长因子受体靶向治疗 III 期和 IV 期头颈部癌症。
Curr Oncol. 2010 Jun;17(3):37-48. doi: 10.3747/co.v17i3.520.
4
A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma.一项多西他赛联合洛铂对比 TPF 方案诱导化疗后同期放化疗治疗局部晚期头颈部鳞癌的前瞻性 II 期随机研究。
J Cancer Res Clin Oncol. 2023 Dec;149(20):18081-18091. doi: 10.1007/s00432-023-05497-1. Epub 2023 Nov 20.
5
Induction Chemotherapy with Cisplatin and 5-Fluorouracil in Advanced Head and Neck Cancers: A Short Term Response Evaluation.顺铂和5-氟尿嘧啶用于晚期头颈癌的诱导化疗:短期疗效评估
J Clin Diagn Res. 2015 Oct;9(10):XC08-XC12. doi: 10.7860/JCDR/2015/12191.6671. Epub 2015 Oct 1.
6
Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis.可切除头颈部鳞状细胞癌患者的诱导化疗:一项荟萃分析。
World J Surg Oncol. 2013 Mar 14;11:67. doi: 10.1186/1477-7819-11-67.
7
Management and outcome of locally advanced oral squamous cell carcinoma.局部晚期口腔鳞状细胞癌的管理与预后
Natl J Maxillofac Surg. 2023 May-Aug;14(2):185-189. doi: 10.4103/njms.njms_125_22. Epub 2023 Jul 13.
8
Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.诱导化疗后序贯同步放化疗与单纯同步放化疗治疗局部晚期头颈部鳞状细胞癌(HNSCC)的比较:一项随机试验的荟萃分析。
Radiother Oncol. 2016 Feb;118(2):238-43. doi: 10.1016/j.radonc.2015.10.014. Epub 2015 Nov 14.
9
A multicenter randomized phase II trial of hyperthermia combined with TPF induction chemotherapy compared with TPF induction chemotherapy in locally advanced resectable oral squamous cell carcinoma.一项多中心随机二期临床试验,比较了高温联合 TPF 诱导化疗与 TPF 诱导化疗在局部晚期可切除口腔鳞状细胞癌中的疗效。
Int J Hyperthermia. 2021;38(1):939-947. doi: 10.1080/02656736.2021.1937714.
10
INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.INGN 201:腺病毒载体p53、Ad5CMV-p53、腺病毒p53、p53基因疗法——英特洛根公司,RPR/INGN 201。
Drugs R D. 2007;8(3):176-87. doi: 10.2165/00126839-200708030-00005.

本文引用的文献

1
Correlation of histopathological patterns of OSCC patients with tumor site and habits.口腔鳞状细胞癌患者的组织病理学模式与肿瘤部位和习惯的相关性。
BMC Oral Health. 2022 Jul 23;22(1):305. doi: 10.1186/s12903-022-02336-6.
2
Operable Oral Tongue Squamous Cell Cancer: 15 Years Experience at a Tertiary Care Center in North India.可手术切除的口腔舌鳞状细胞癌:印度北部一家三级医疗中心的15年经验
Indian J Surg Oncol. 2018 Mar;9(1):15-23. doi: 10.1007/s13193-017-0658-x. Epub 2017 May 11.
3
The prevalence of squamous cell carcinoma in different sites of oral cavity at our Rural Health Care Centre in Loni, Maharashtra - a retrospective 10-year study.马哈拉施特拉邦洛尼市我们农村医疗中心口腔不同部位鳞状细胞癌的患病率——一项为期10年的回顾性研究。
Contemp Oncol (Pozn). 2017;21(2):178-183. doi: 10.5114/wo.2017.68628. Epub 2017 Jun 30.
4
Neck dissection for oral squamous cell carcinoma: our experience and a review of the literature.口腔鳞状细胞癌的颈淋巴结清扫术:我们的经验及文献综述
J Korean Assoc Oral Maxillofac Surg. 2015 Dec;41(6):299-305. doi: 10.5125/jkaoms.2015.41.6.299. Epub 2015 Dec 17.
5
Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.择期性与治疗性颈清扫术在淋巴结阴性口腔癌中的应用。
N Engl J Med. 2015 Aug 6;373(6):521-9. doi: 10.1056/NEJMoa1506007. Epub 2015 May 31.
6
Head and neck cancers in developing countries.发展中国家的头颈癌
Rambam Maimonides Med J. 2014 Apr 28;5(2):e0009. doi: 10.5041/RMMJ.10143. eCollection 2014 Apr.
7
Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.诱导选择化疗与原发手术治疗晚期口腔癌患者的疗效比较。
JAMA Otolaryngol Head Neck Surg. 2014 Feb;140(2):134-42. doi: 10.1001/jamaoto.2013.5892.
8
Induction chemotherapy in technically unresectable locally advanced oral cavity cancers: does it make a difference?技术上无法切除的局部晚期口腔癌的诱导化疗:有区别吗?
Indian J Cancer. 2013 Jan-Mar;50(1):1-8. doi: 10.4103/0019-509X.112263.
9
Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis.可切除头颈部鳞状细胞癌患者的诱导化疗:一项荟萃分析。
World J Surg Oncol. 2013 Mar 14;11:67. doi: 10.1186/1477-7819-11-67.
10
A comprehensive review of head and neck cancer rehabilitation: physical therapy perspectives.头颈部癌症康复的全面综述:物理治疗视角
Indian J Palliat Care. 2012 May;18(2):87-97. doi: 10.4103/0973-1075.100820.

局部晚期头颈部鳞状细胞癌诱导化疗前后手术可切除性的比较评估

Comparative Evaluation of Surgical Operability with and without Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.

作者信息

Yelishetty Haraprathap, Yadav Jitendra Singh, Sethi Chandni, Chaurasia Rachna, Singh Mayank, Mahur Sachin, Tripathi Shalini, Bam Bomkar, Gupta Shraddha

机构信息

Maharani Laxmi Bai Medical College, Jhansi, India.

出版信息

Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):626-632. doi: 10.1007/s12070-023-04230-1. Epub 2023 Oct 3.

DOI:10.1007/s12070-023-04230-1
PMID:38440429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10908765/
Abstract

To compare and evaluation of surgical operability with and without induction chemotherapy in locally advanced head and neck squamous cell carcinoma. Head and neck malignancy grossly refers to squamous cell carcinomas of head and neck (HNSCC) have multiple treatment modalities and strategies, when opted in an appropriate manner renders tumours curable. The aim of this study is to compare and evaluation of surgical operability with and without induction chemotherapy in locally advanced head and neck squamous cell carcinoma. A prospective observational study involving 50 patients of histologically proven squamous cell carcinoma of head and neck region. Patients were categorized into two major groups, group-1 patients included resectable tumour stage and group-2 included unresectable tumour stage. Both groups were compared after appropriate chemotherapy and surgical intervention. There were a total of 78% males and 22% females with majority of patients in age group of 41-60 years. 54% patients had ulcerative type of growth pattern and most patients had primary site of lesion in oral cavity. 50% patients had moderately differentiated squamous cell carcinoma. Induction chemotherapy was considered in 70% of patients, while majority of patients were belonging to T4N2M0 stage. In this study, we recommend that the borderline category of patients who are initially in an unresectable tumour stage can undergo induction chemotherapy to downstage and shrink the tumour to a resectable stage following which the appropriate surgical intervention should be done with a close monitoring and sustained follow up to prevent recurrence.

摘要

比较和评估诱导化疗前后局部晚期头颈部鳞状细胞癌的手术可操作性。头颈部恶性肿瘤大体上指头颈部鳞状细胞癌(HNSCC),有多种治疗方式和策略,若选择得当可使肿瘤治愈。本研究的目的是比较和评估诱导化疗前后局部晚期头颈部鳞状细胞癌的手术可操作性。一项前瞻性观察性研究,纳入50例经组织学证实的头颈部鳞状细胞癌患者。患者分为两大组,第1组患者包括可切除肿瘤分期,第2组包括不可切除肿瘤分期。两组在进行适当的化疗和手术干预后进行比较。共有78%为男性,22%为女性,大多数患者年龄在41 - 60岁。54%的患者有溃疡性生长模式,大多数患者病变原发部位在口腔。50%的患者为中分化鳞状细胞癌。70%的患者接受了诱导化疗,而大多数患者属于T4N2M0期。在本研究中,我们建议最初处于不可切除肿瘤分期的临界患者可接受诱导化疗以使肿瘤降期并缩小至可切除阶段,之后应进行适当的手术干预,并密切监测和持续随访以预防复发。